LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 43 filers reported holding LEAP THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,074 | -24.4% | 6,100 | 0.0% | 0.00% | – |
Q4 2022 | $2,745 | -45.1% | 6,100 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | -28.6% | 6,100 | 0.0% | 0.00% | – |
Q2 2022 | $7,000 | -36.4% | 6,100 | 0.0% | 0.00% | – |
Q1 2022 | $11,000 | -45.0% | 6,100 | 0.0% | 0.00% | – |
Q4 2021 | $20,000 | -16.7% | 6,100 | 0.0% | 0.00% | – |
Q3 2021 | $24,000 | +140.0% | 6,100 | 0.0% | 0.00% | – |
Q2 2021 | $10,000 | -16.7% | 6,100 | 0.0% | 0.00% | – |
Q1 2021 | $12,000 | -14.3% | 6,100 | 0.0% | 0.00% | – |
Q4 2020 | $14,000 | +16.7% | 6,100 | 0.0% | 0.00% | – |
Q3 2020 | $12,000 | -7.7% | 6,100 | 0.0% | 0.00% | – |
Q2 2020 | $13,000 | +30.0% | 6,100 | 0.0% | 0.00% | – |
Q1 2020 | $10,000 | +42.9% | 6,100 | 0.0% | 0.00% | – |
Q4 2019 | $7,000 | 0.0% | 6,100 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | -36.4% | 6,100 | 0.0% | 0.00% | – |
Q2 2019 | $11,000 | 0.0% | 6,100 | 0.0% | 0.00% | – |
Q1 2019 | $11,000 | -8.3% | 6,100 | 0.0% | 0.00% | – |
Q4 2018 | $12,000 | -75.0% | 6,100 | 0.0% | 0.00% | – |
Q3 2018 | $48,000 | – | 6,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 16,952,992 | $27,802,000 | 0.18% |
Opaleye Management Inc. | 540,000 | $886,000 | 0.15% |
ACT CAPITAL MANAGEMENT, LLC | 134,000 | $220,000 | 0.11% |
Artal Group S.A. | 3,000,000 | $4,920,000 | 0.10% |
HHLR ADVISORS, LTD. | 3,575,745 | $5,864,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 910,047 | $1,492,000 | 0.04% |
PERSONAL CFO SOLUTIONS, LLC | 78,165 | $128,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 122,401 | $201,000 | 0.02% |
Windsor Creek Advisors, LLC | 46,955 | $77,000 | 0.02% |
Golden Green, Inc. | 14,824 | $24,000 | 0.02% |